Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes
- PMID: 22257840
- PMCID: PMC3360983
- DOI: 10.1038/gene.2011.89
Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes
Abstract
We fine mapped two primary biliary cirrhosis (PBC) risk loci, CLEC16A (C-type lectin domain family 16 member A)-suppressor of cytokine signaling 1 (SOCS1) and Spi-B protein (SPIB) and sequenced a locus, sialic acid acetylesterase (SIAE), proposed to harbor autoimmunity-associated mutations. In all, 1450 PBC cases and 2957 healthy controls were genotyped for 84 single-nucleotide polymorphisms (SNPs) across the CLEC16A-SOCS1 and SPIB loci. All 10 exons of the SIAE gene were resequenced in 381 cases and point substitutions of unknown significance assayed for activity and secretion. Fine mapping identified 26 SNPs across the CLEC16A-SOCS1 and 11 SNPs across the SPIB locus with significant association to PBC, the strongest signals at the CLEC16A-SOCS1 locus emanating from a SOCS1 intergenic SNP (rs243325; P=9.91 × 10(-9)) and at the SPIB locus from a SPIB intronic SNP (rs34944112; P=3.65 × 10(-9)). Among the associated SNPs at the CLEC16A-SOCS1 locus, two within the CLEC16A gene as well as one SOCS1 SNP (rs243325) remained significant after conditional logistic regression and contributed independently to risk. Sequencing of the SIAE gene and functional assays of newly identified variants revealed six patients with functional non-synonymous SIAE mutations (Fisher's P=9 × 10(-4) vs controls) We demonstrate independent effects on risk of PBC for CLEC16A, SOCS1 and SPIB variants, while identifying functionally defective SIAE variants as potential factors in risk for PBC.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ. Primary biliary cirrhosis. Hepatology. 2009;50:291–308. - PubMed
-
- Hirschfield GM, Heathcote EJ, Gershwin ME. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology. 2010;139:1481–1496. - PubMed
-
- Hirschfield GM, Gershwin ME. Primary biliary cirrhosis: one disease with many faces. Isr Med Assoc J. 2011;13:55–59. - PubMed
-
- Hirschfield GM, Invernizzi P. Progress in the genetics of primary biliary cirrhosis. Semin Liver Dis. 2011;31:147–156. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UC2 HL103010/HL/NHLBI NIH HHS/United States
- R01 DK80670/DK/NIDDK NIH HHS/United States
- R01 AI090867/AI/NIAID NIH HHS/United States
- MOP74621/CAPMC/ CIHR/Canada
- AR 058481/AR/NIAMS NIH HHS/United States
- AI 064930/AI/NIAID NIH HHS/United States
- RC2 HL102923/HL/NHLBI NIH HHS/United States
- UC2 HL102926/HL/NHLBI NIH HHS/United States
- RC1 AR058481/AR/NIAMS NIH HHS/United States
- RC2 HL102926/HL/NHLBI NIH HHS/United States
- R01 DK080670/DK/NIDDK NIH HHS/United States
- R01 AI064930/AI/NIAID NIH HHS/United States
- RC2 HL102924/HL/NHLBI NIH HHS/United States
- AI 076505/AI/NIAID NIH HHS/United States
- UC2 HL102923/HL/NHLBI NIH HHS/United States
- UC2 HL102924/HL/NHLBI NIH HHS/United States
- R01 AI076505/AI/NIAID NIH HHS/United States
- RC2 HL103010/HL/NHLBI NIH HHS/United States
- RC2 HL102925/HL/NHLBI NIH HHS/United States
- UC2 HL102925/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
